Lax FDA oversight spurred a nascent industry of antibody test makers, with companies jockeying to cash in, a USA TODAY investigation found.
Breaking News & Events
Lax FDA oversight spurred a nascent industry of antibody test makers, with companies jockeying to cash in, a USA TODAY investigation found.